香港股市 已收市

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM 延遲價格。貨幣為 USD。
加入追蹤清單
0.6355-0.0745 (-10.49%)
收市:04:00PM EDT
0.6355 0.00 (0.00%)
收市後: 07:38PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價0.7100
開市0.7199
買盤0.6010 x 100
賣出價0.6720 x 100
今日波幅0.6300 - 0.7300
52 週波幅0.5000 - 90.6500
成交量458,327
平均成交量2,774,856
市值4.827M
Beta 值 (5 年,每月)0.58
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-108.9700
業績公佈日
遠期股息及收益率無 (無)
除息日
1 年預測目標價8.00
  • Benzinga

    Why Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today?

    ZyVersa Therapeutics Inc (NASDAQ:ZVSA) announces the publication of an article in the peer-reviewed journal Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with triple-negative breast cancer (TNBC). Up to 40% of women with TNBC experience metastasis to their brain. Published data demonstrate that inflammasome activation increases the proliferation of TNBC cells in the brain, which was prevented by inhibition of NLR